CMD reaffirms the 2030 roadmap

01/10/26 -"EVN’s CMD offered little new, broadly confirming the targets flagged at the FY24/25 results, with 2030 EBITDA of €1.2bn at the top end of guidance, alongside a €500m net result and €1bn of ..."

Executive summary
Conflict of interest

Pages

Language

English

Published on

01/10/26

Download

You may also be interested by these reports :

01/10/26

EVN

EVN’s CMD offered little new, broadly confirming the targets flagged at the FY24/25 results, with 2030 EBITDA of €1.2bn at the top end of guidance, ...

30/09/26

Valuation Wise

Should one chase the 5.7% yield that Real Estate dangles? Or forget yield altogether, buy Semiconductors and pray? Below is the pecking order of ...

16/09/26

Valuation Wise

Reading European equities earnings dynamic, i.e. revisions, remains a brain torturing exercise for anyone wondering where the 2026 earnings growth at ...

10/09/26

European Utilities

Europe’s empty tanks, how to trade a winter with no safety net?

EXECUTIVE SUMMARY

Updates

Pension Risks

Target & Opinion

Governance & Management

Business & Trends

Graphics : Momentum

Money Making

Graphics : MACD & Volumes

Debt

Graphics : Sensitivities

Valuation

Sector: Performance

DCF

Sector: Key data

NAV/SOTP

Sector: Ratios & Valorisation

Worth knowing

Sector: Peers

Financials

Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking

Trading in corporate shares

Analyst ownership

Advising of corporate (strategy, marketing, debt, etc)

Research paid for by corporate

Provision of corporate access paid for by corporate

Link between and a banking entity

Brokerage activity at AlphaValue